Yibai Pharmaceutical expects first-half net loss of 74 million to 88.8 million yuan, widening year-on-year

Earnings
โดย 北京商报·Read original
Summary · why it matters

Yibai Pharmaceutical has released its 2026 half-year performance forecast, expecting a net loss attributable to shareholders of 74 million to 88.8 million yuan, compared with a loss of 19.9021 million yuan in the same period last year, widening the loss year-on-year. The company said that during the reporting period, sales of its main products declined, leading to an expected 30 percent drop in revenue. Although costs and expenses are expected to fall by 26 percent, they still exceed revenue, resulting in the loss.

Impact on stocks 1

Others▼ · 1 stocks
© 2026 MarketDXNews